Financial Snapshot

Revenue
$555.5M
TTM
Gross Margin
59.83%
TTM
Net Earnings
-$7.547M
TTM
Current Assets
Q3 2024
Current Liabilities
Q3 2024
Current Ratio
274.46%
Q3 2024
Total Assets
Q3 2024
Total Liabilities
Q3 2024
Book Value
$430.8M
Q3 2024
Cash
Q3 2024
P/E
-158.4
Nov 29, 2024 EST
Free Cash Flow
$76.78M
TTM

Revenues

Revenues

Loading...

Revenue YoY Change

Loading...

Revenues

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998
Revenue $486.8M $316.4M $216.1M $208.5M $206.5M $201.6M $176.8M $128.6M $76.32M $55.97M $30.08M $20.37M $435.2K $2.474M $1.258M $3.800M $500.0K $14.40M $300.0K $100.0K $100.0K $2.800M $1.700M $0.00 $0.00 $0.00
YoY Change 53.87% 46.38% 3.67% 0.93% 2.47% 13.99% 37.49% 68.53% 36.36% 86.06% 47.67% 4581.27% -82.41% 96.67% -66.89% 660.0% -96.53% 4700.0% 200.0% 0.0% -96.43% 64.71%

Expenses

Cost Of Revenues

Loading...

Gross Profit

Loading...

Gross Profit Margin

Loading...

Gross Profit

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998
Revenue $486.8M $316.4M $216.1M $208.5M $206.5M $201.6M $176.8M $128.6M $76.32M $55.97M $30.08M $20.37M $435.2K $2.474M $1.258M $3.800M $500.0K $14.40M $300.0K $100.0K $100.0K $2.800M $1.700M $0.00 $0.00 $0.00
Cost Of Revenue $181.5M $138.8M $100.6M $87.16M $63.15M $73.02M $79.03M $48.78M $12.69M $11.47M $9.974M $9.167M $100.0K $300.0K $300.0K $800.0K $0.00 $3.500M $0.00 $600.0K
Gross Profit $305.3M $177.6M $115.5M $121.3M $143.4M $128.6M $97.81M $79.84M $63.63M $44.50M $20.11M $11.20M $400.0K $2.200M $1.000M $3.000M $500.0K $10.90M $300.0K -$500.0K
Gross Profit Margin 62.71% 56.13% 53.45% 58.19% 69.42% 63.77% 55.31% 62.07% 83.37% 79.5% 66.84% 55.0% 91.92% 88.92% 79.49% 78.95% 100.0% 75.69% 100.0% -500.0%

Selling, General & Admin Expense

Loading...

Research & Development

Loading...

Depreciation, Depletion & Amortization

Loading...

SGA Expense to Gross Profit Ratio

Loading...

R&D To Gross Profit Ratio

Loading...

DDA To Gross Profit Ratio

Loading...

Operating Expenses Total

Loading...

Operating Profits/Loss

Loading...

Operational Expenses

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998
Selling, General & Admin $161.7M $124.0M $84.29M $64.99M $55.84M $44.06M $31.58M $27.83M $21.16M $17.94M $16.39M $9.521M $7.000M $5.900M $5.400M $5.100M $4.300M $4.500M $3.800M $2.700M $2.300M $1.800M $2.300M $1.700M $900.0K $1.100M
YoY Change 30.35% 47.16% 29.71% 16.37% 26.73% 39.53% 13.48% 31.54% 17.96% 9.44% 72.12% 36.01% 18.64% 9.26% 5.88% 18.6% -4.44% 18.42% 40.74% 17.39% 27.78% -21.74% 35.29% 88.89% -18.18%
% of Gross Profit 52.96% 69.84% 72.97% 53.57% 38.94% 34.28% 32.29% 34.86% 33.25% 40.31% 81.5% 84.98% 1750.0% 268.18% 540.0% 170.0% 860.0% 41.28% 1266.67%
Research & Development $34.29M $22.30M $11.40M $16.00M $19.80M $15.40M $9.070M $2.906M $2.874M $2.678M $1.712M $1.158M $44.18M $39.71M $13.68M $15.80M $4.800M $3.900M $6.400M $9.000M $3.700M $4.800M $2.100M $1.900M $700.0K $1.400M
YoY Change 53.75% 95.61% -28.75% -19.19% 28.57% 69.79% 212.11% 1.11% 7.32% 56.43% 47.84% -97.38% 11.27% 190.23% -13.41% 229.17% 23.08% -39.06% -28.89% 143.24% -22.92% 128.57% 10.53% 171.43% -50.0%
% of Gross Profit 11.23% 12.56% 9.87% 13.19% 13.81% 11.98% 9.27% 3.64% 4.52% 6.02% 8.51% 10.34% 11045.57% 1804.8% 1368.06% 526.67% 960.0% 35.78% 2133.33%
Depreciation & Amortization $7.500M $7.400M $47.25M $44.64M $44.61M $33.74M $27.93M $22.34M $6.900M $3.878M $1.110M $567.0K $148.2K $168.0K $137.3K $40.00K $90.00K $120.0K $100.0K $100.0K $90.00K $90.00K $90.00K $100.0K $90.00K $140.0K
YoY Change 1.35% -84.34% 5.86% 0.06% 32.22% 20.82% 25.0% 223.81% 77.93% 249.37% 95.77% 282.49% -11.75% 22.37% 243.2% -55.56% -25.0% 20.0% 0.0% 11.11% 0.0% 0.0% -10.0% 11.11% -35.71%
% of Gross Profit 2.46% 4.17% 40.9% 36.79% 31.11% 26.25% 28.55% 27.98% 10.84% 8.72% 5.52% 5.06% 37.06% 7.64% 13.73% 1.33% 18.0% 1.1% 33.33%
Operating Expenses $196.0M $146.3M $95.69M $80.99M $75.64M $59.46M $40.65M $30.74M $24.03M $20.61M $18.10M $10.68M $44.18M $39.71M $13.68M $21.00M $9.200M $8.600M $10.30M $11.70M $6.100M $6.600M $4.500M $3.700M $1.600M $2.700M
YoY Change 33.92% 52.93% 18.16% 7.06% 27.21% 46.28% 32.26% 27.9% 16.58% 13.88% 69.49% -75.83% 11.27% 190.23% -34.85% 128.26% 6.98% -16.5% -11.97% 91.8% -7.58% 46.67% 21.62% 131.25% -40.74%
Operating Profit $46.97M -$35.28M -$39.79M -$16.02M $16.35M $35.36M $28.33M $20.08M $32.70M $20.01M $898.0K -$42.00K -$43.78M -$37.51M -$12.68M -$18.00M -$8.700M $2.300M -$10.00M -$12.20M
YoY Change -233.13% -11.33% 148.46% -197.95% -53.76% 24.82% 41.09% -38.6% 63.45% 2127.84% -2238.1% -99.9% 16.74% 195.77% -29.55% 106.9% -478.26% -123.0% -18.03%

Interest Expenses

Loading...

Interest Expenses To Operating Income %

Loading...

Other Expense/Income

Loading...

Interest & Other Expense/Income

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998
Interest Expense -$26.94M -$28.05M -$11.92M -$9.452M -$12.97M -$14.76M -$12.04M -$11.33M -$11.01M -$787.0K $467.0K $1.327M $681.6K $688.1K $147.0K $600.0K $1.100M $400.0K $400.0K $300.0K $100.0K $100.0K $200.0K $200.0K $200.0K $100.0K
YoY Change -3.96% 135.3% 26.13% -27.1% -12.14% 22.63% 6.25% 2.9% 1298.73% -268.52% -64.81% 94.7% -0.95% 368.0% -75.5% -45.45% 175.0% 0.0% 33.33% 200.0% 0.0% -50.0% 0.0% 0.0% 100.0%
% of Operating Profit -57.35% -79.3% -41.74% -42.48% -56.41% -33.66% -3.93% 52.0% 17.39%
Other Income/Expense, Net -$159.0K $670.0K -$4.343M -$494.0K -$228.0K -$550.0K $55.00K -$74.00K $41.00K $160.0K -$305.0K -$241.0K $200.0K $0.00 $0.00
YoY Change -123.73% -115.43% 779.15% 116.67% -58.55% -1100.0% -174.32% -280.49% -74.38% -152.46% 26.56%

Income/Loss

Pretax Income

Loading...

Income Tax

Loading...

Net Profits/Loss

Loading...

Pretax Income YoY Change

Loading...

Income Tax Rate

Loading...

Net Profits/Loss YoY Change

Loading...

Basic EPS

Loading...

Net Income To Revenue Ratio

Loading...

Pretax & Net Income

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998
Pretax Income $19.87M -$62.67M -$56.06M -$25.96M $3.157M $20.05M $16.35M $8.678M $21.73M $19.38M $126.0K -$1.610M -$51.61M -$46.20M -$47.50M -$17.40M -$7.600M $2.800M -$9.700M -$12.00M -$6.000M -$3.800M -$2.600M -$3.400M -$1.400M -$2.700M
YoY Change -131.71% 11.79% 115.92% -922.36% -84.26% 22.64% 88.4% -60.07% 12.15% 15280.16% -107.83% -96.88% 11.72% -2.74% 172.99% 128.95% -371.43% -128.87% -19.17% 100.0% 57.89% 46.15% -23.53% 142.86% -48.15%
Income Tax $1.093M -$14.77M -$13.46M -$3.414M -$2.937M $4.557M $17.43M $4.744M $6.358M -$9.368M $20.00K -$36.00K $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
% Of Pretax Income 5.5% -93.03% 22.73% 106.58% 54.67% 29.26% -48.34% 15.87% 0.0%
Net Earnings $18.78M -$47.90M -$42.60M -$22.55M $6.094M $15.49M -$1.076M $3.934M $15.38M $28.75M $301.0K -$1.506M -$51.60M -$46.20M -$47.50M -$17.40M -$7.600M $2.800M -$9.700M -$12.00M -$6.000M -$3.800M -$2.600M -$3.400M -$1.400M -$2.700M
YoY Change -139.21% 12.42% 88.94% -470.0% -60.67% -1539.96% -127.35% -74.41% -46.52% 9450.5% -119.99% -97.08% 11.69% -2.74% 172.99% 128.95% -371.43% -128.87% -19.17% 100.0% 57.89% 46.15% -23.53% 142.86% -48.15%
Net Earnings / Revenue 3.86% -15.14% -19.71% -10.82% 2.95% 7.69% -0.61% 3.06% 20.14% 51.36% 1.0% -7.39% -11857.71% -1867.24% -3775.67% -457.89% -1520.0% 19.44% -3233.33% -12000.0% -6000.0% -135.71% -152.94%
Basic Earnings Per Share $0.86 -$3.05 -$3.40 -$1.88 $0.51 $1.31 -$0.09 $0.34 $1.34 $2.61 -$0.92 -$1.27 -$3.15 -$4.21 -$8.40
Diluted Earnings Per Share $0.85 -$3.05 -$3.40 -$1.88 $0.50 $1.30 -$0.09 $0.34 $1.32 $2.59 -$0.92 -$1.27 -$3.15 -$4.21 -$8.40 -$21.75M -$10.86M $4.667M -$19.40M -$24.00M -$20.00M -$19.00M -$13.00M -$17.00M -$14.00M -$27.00M

Assets & Liabilities

Cash & Short-Term Investments

Loading...

Cash & Equivalents

Loading...

Cash To Operating Expenses Ratio

Loading...

Inventory

Loading...

Receivables

Loading...

Total Short-Term Assets

Loading...

Property, Plant And Equipment

Loading...

Long-Term Investments

Loading...

Total Long-Term Assets

Loading...

Total Assets

Loading...

Net Income To Total Assets Percentage

Loading...

Accounts Payable

Loading...

Short-Term Debt

Loading...

Long Term Debt Due

Loading...

Total Short-Term Liabilities

Loading...

Long-Term Debt

Loading...

Other Long-Term Liabilities

Loading...

Total Long-Term Liabilities

Loading...

Total Liabilities

Loading...

Short-Term To Long-Term Debt Ratio

Loading...

Short-Term Assets To Debt Ratio

Loading...

Long-Term Debt To Net Income Ratio

Loading...

Assets & Liabilities

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998
Cash & Short-Term Investments $221.1M $48.23M $100.3M $7.900M $62.30M $43.00M $31.10M $27.40M $154.7M $169.0M $11.10M $0.00 $57.20M $38.20M $29.90M $14.80M $30.70M $11.50M $9.100M $17.30M $9.100M $4.900M $4.500M $2.600M $5.300M $100.0K
YoY Change 358.49% -51.92% 1169.62% -87.32% 44.88% 38.26% 13.5% -82.29% -8.46% 1422.52% -100.0% 49.74% 27.76% 102.03% -51.79% 166.96% 26.37% -47.4% 90.11% 85.71% 8.89% 73.08% -50.94% 5200.0%
Cash & Equivalents $221.1M $48.23M $100.3M $7.900M $62.30M $43.00M $31.10M $27.40M $154.7M $169.0M $11.10M $0.00 $57.20M $38.20M $29.90M $11.80M $15.60M $7.700M $300.0K $1.200M $9.100M $4.900M $4.500M $2.600M $5.300M
Short-Term Investments $0.00 $3.000M $15.00M $3.800M $8.800M $16.10M $0.00 $100.0K
Other Short-Term Assets $25.42M $21.41M $7.589M $5.900M $4.000M $4.500M $2.800M $3.600M $1.500M $1.100M $600.0K $300.0K $800.0K $2.500M $1.500M $1.100M $300.0K $200.0K $200.0K $300.0K $200.0K $600.0K $100.0K $100.0K $100.0K $2.800M
YoY Change 18.71% 182.16% 28.63% 47.5% -11.11% 60.71% -22.22% 140.0% 36.36% 83.33% 100.0% -62.5% -68.0% 66.67% 36.36% 266.67% 50.0% 0.0% -33.33% 50.0% -66.67% 500.0% 0.0% 0.0% -96.43%
Inventory $111.2M $105.4M $81.69M $60.80M $48.20M $40.50M $37.70M $26.20M $13.40M $7.500M $3.500M $2.800M
Prepaid Expenses
Receivables $162.1M $165.4M $128.5M $95.80M $72.10M $64.80M $58.80M $45.90M $21.90M $17.30M $12.50M $5.400M $0.00 $100.0K $200.0K $0.00 $10.50M $0.00
Other Receivables $0.00 $3.827M $3.667M $0.00 $1.100M $0.00 $1.200M $0.00 $1.200M $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Total Short-Term Assets $519.8M $344.3M $321.8M $170.3M $187.7M $152.9M $131.6M $103.0M $192.6M $195.0M $27.70M $8.600M $58.00M $40.60M $31.40M $16.10M $31.00M $22.20M $9.300M $17.60M $9.300M $5.500M $4.600M $2.700M $5.300M $2.900M
YoY Change 50.99% 6.99% 88.95% -9.27% 22.76% 16.19% 27.77% -46.52% -1.23% 603.97% 222.09% -85.17% 42.86% 29.3% 95.03% -48.06% 39.64% 138.71% -47.16% 89.25% 69.09% 19.57% 70.37% -49.06% 82.76%
Property, Plant & Equipment $44.59M $43.25M $52.67M $41.30M $40.60M $38.10M $20.40M $11.00M $7.100M $5.200M $4.500M $4.900M $900.0K $600.0K $700.0K $800.0K $100.0K $100.0K $200.0K $200.0K $200.0K $300.0K $400.0K $400.0K $400.0K $500.0K
YoY Change 3.11% -17.89% 27.53% 1.72% 6.56% 86.76% 85.45% 54.93% 36.54% 15.56% -8.16% 444.44% 50.0% -14.29% -12.5% 700.0% 0.0% -50.0% 0.0% 0.0% -33.33% -25.0% 0.0% 0.0% -20.0%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $3.400M $3.400M $3.600M $100.0K $100.0K $0.00
YoY Change 0.0% -5.56% 3500.0% 0.0%
Other Assets $102.8M $92.72M $75.14M $57.50M $44.60M $34.50M $28.50M $31.20M $17.30M $15.40M $0.00 $200.0K $100.0K $100.0K $700.0K $600.0K $0.00 $0.00 $0.00 $0.00
YoY Change 10.85% 23.4% 30.68% 28.92% 29.28% 21.05% -8.65% 80.35% 12.34% -100.0% 100.0% 0.0% -85.71% 16.67%
Total Long-Term Assets $384.6M $415.8M $449.8M $290.9M $269.1M $277.7M $280.5M $219.9M $92.70M $64.60M $16.80M $5.100M $4.400M $4.200M $5.000M $1.600M $200.0K $200.0K $300.0K $200.0K $300.0K $400.0K $400.0K $400.0K $500.0K $500.0K
YoY Change -7.51% -7.56% 54.63% 8.1% -3.1% -1.0% 27.56% 137.22% 43.5% 284.52% 229.41% 15.91% 4.76% -16.0% 212.5% 700.0% 0.0% -33.33% 50.0% -33.33% -25.0% 0.0% 0.0% -20.0% 0.0%
Total Assets $904.4M $760.1M $771.6M $461.2M $456.8M $430.6M $412.1M $322.9M $285.3M $259.6M $44.50M $13.70M $62.40M $44.80M $36.40M $17.70M $31.20M $22.40M $9.600M $17.80M $9.600M $5.900M $5.000M $3.100M $5.800M $3.400M
YoY Change
Accounts Payable $36.68M $29.31M $22.97M $11.30M $14.60M $8.900M $3.600M $3.400M $2.100M $2.700M $1.400M $2.000M $3.200M $4.900M $2.400M $3.200M $700.0K $600.0K $1.100M $1.200M $200.0K $500.0K $100.0K $0.00 $100.0K $100.0K
YoY Change 25.18% 27.6% 103.25% -22.6% 64.04% 147.22% 5.88% 61.9% -22.22% 92.86% -30.0% -37.5% -34.69% 104.17% -25.0% 357.14% 16.67% -45.45% -8.33% 500.0% -60.0% 400.0% -100.0% 0.0%
Accrued Expenses $57.84M $35.89M $27.80M $22.90M $20.10M $22.70M $24.00M $20.40M $7.000M $4.900M $1.400M $900.0K $4.100M $2.200M $1.500M $700.0K $800.0K $400.0K $600.0K $700.0K $600.0K $600.0K $400.0K $400.0K $200.0K $600.0K
YoY Change 61.17% 29.07% 21.41% 13.93% -11.45% -5.42% 17.65% 191.43% 42.86% 250.0% 55.56% -78.05% 86.36% 46.67% 114.29% -12.5% 100.0% -33.33% -14.29% 16.67% 0.0% 50.0% 0.0% 100.0% -66.67%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $4.100M $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
YoY Change -100.0%
Long-Term Debt Due $850.0K $850.0K $850.0K $13.20M $9.900M $115.7M $3.400M $0.00 $1.100M $0.00 $0.00 $500.0K $0.00
YoY Change 0.0% 0.0% -93.56% 33.33% -91.44% 3302.94% -100.0% -100.0%
Total Short-Term Liabilities $145.5M $99.44M $87.54M $78.60M $61.70M $165.5M $39.20M $31.90M $11.80M $13.20M $3.500M $7.700M $7.200M $8.200M $3.900M $3.900M $1.500M $4.300M $2.700M $1.900M $900.0K $1.300M $900.0K $900.0K $300.0K $800.0K
YoY Change 46.3% 13.6% 11.37% 27.39% -62.72% 322.19% 22.88% 170.34% -10.61% 277.14% -54.55% 6.94% -12.2% 110.26% 0.0% 160.0% -65.12% 59.26% 42.11% 111.11% -30.77% 44.44% 0.0% 200.0% -62.5%
Long-Term Debt $284.8M $285.7M $286.5M $172.4M $175.8M $67.30M $198.2M $120.6M $113.4M $106.5M $0.00 $48.80M $17.30M $17.40M $16.70M $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
YoY Change -0.3% -0.3% 66.19% -1.93% 161.22% -66.04% 64.34% 6.35% 6.48% -100.0% 182.08% -0.57% 4.19%
Other Long-Term Liabilities $16.53M $36.44M $38.80M $14.50M $6.500M $500.0K $0.00 $600.0K $0.00 $100.0K $0.00
YoY Change -54.64% -6.09% 167.59% 123.08% 1200.0% -100.0% -100.0%
Total Long-Term Liabilities $301.3M $322.1M $325.3M $186.9M $182.3M $67.80M $198.2M $121.2M $113.4M $106.5M $0.00 $48.80M $17.30M $17.40M $16.70M $0.00 $0.00 $0.00 $100.0K $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
YoY Change -6.45% -0.99% 74.06% 2.52% 168.88% -65.79% 63.53% 6.88% 6.48% -100.0% 182.08% -0.57% 4.19% -100.0%
Total Liabilities $446.8M $421.5M $412.9M $265.5M $244.0M $233.3M $237.4M $153.2M $125.2M $119.8M $3.500M $56.50M $24.60M $25.60M $20.60M $3.900M $1.500M $4.300M $2.800M $1.900M $900.0K $1.300M $900.0K $900.0K $300.0K $800.0K
YoY Change 6.0% 2.1% 55.5% 8.81% 4.59% -1.73% 54.96% 22.36% 4.51% 3322.86% -93.81% 129.67% -3.91% 24.27% 428.21% 160.0% -65.12% 53.57% 47.37% 111.11% -30.77% 44.44% 0.0% 200.0% -62.5%

Ownership

Basic Shares Outstanding

Loading...

Diluted Shares Outstanding

Loading...

Preferred Stock

Loading...

Treasury Stock Shares

Loading...

Stock Issuance & Repurchase

Loading...

Ownership Data

Return On Shareholders' Equity

Loading...

Book Value

Loading...

Free Cash Flow

Loading...

Free Cash Flow YoY

Loading...

Free Cash Flow Margin

Loading...

Dividends

Dividends

Loading...

Stock Price

Loading...
Market Cap: $1.1957 Billion

About ANI PHARMACEUTICALS INC

ANI Pharmaceuticals, Inc. is a bio-pharmaceutical company, which engages in the development, manufacture, and marketing of branded and generic prescription pharmaceuticals. The company is headquartered in Baudette, Minnesota and currently employs 642 full-time employees. The company went IPO on 2000-05-04. The firm is focused on delivering sustainable growth by scaling up its Rare Disease business through its lead asset, Purified Cortrophin Gel, as well as its generics business with enhanced research and development capabilities. Its three pharmaceutical manufacturing facilities, of which two are located in Baudette, Minnesota, and one is located in East Windsor, New Jersey, are together capable of producing oral solid dose products, as well as semi-solids, liquids and topicals, controlled substances, and potent products. The firm has a commercial portfolio of approximately 118 products with a variety of indications and a robust portfolio of pipeline products.

Industry: Pharmaceutical Preparations Peers: Atea Pharmaceuticals, Inc. BIODELIVERY SCIENCES INTERNATIONAL INC COLLEGIUM PHARMACEUTICAL, INC Edgewise Therapeutics, Inc. NEKTAR THERAPEUTICS JOHNSON & JOHNSON PHIBRO ANIMAL HEALTH CORP Tricida, Inc.